Exact Mass: 418.2872

Exact Mass Matches: 418.2872

Found 58 metabolites which its exact mass value is equals to given mass value 418.2872, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Palmitoyl glucuronide

(2S,3S,4S,5R,6R)-6-(hexadecyloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C22H42O7 (418.293)


Palmitoyl glucuronide is a natural human metabolite of Palmitic acid generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Palmitoyl glucuronide is a natural human metabolite of Palmitic acid generated in the liver by UDP glucuonyltransferase.

   

N-Arachidonoyl Asparagine

3-(C-Hydroxycarbonimidoyl)-2-[(1-hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]propanoate

C24H38N2O4 (418.2831)


N-arachidonoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Valbenazine

L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester;L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester

C24H38N2O4 (418.2831)


   
   
   

Boneratamide B methyl ester

(+)-Boneratamide B methyl ester

C24H38N2O4 (418.2831)


   

Boneratamide C methyl ester

(+)-Boneratamide C methyl ester

C24H38N2O4 (418.2831)


   

3,7,11,15-tetramethyl-n-octadec-13-ene-3,4,6,7,8,11-hexol-12-one

3,7,11,15-tetramethyl-n-octadec-13-ene-3,4,6,7,8,11-hexol-12-one

C22H42O7 (418.293)


   

9-Hydroxy-9-apo-epsilon-caroten-3-one

9-Hydroxy-9-apo-epsilon-caroten-3-one

C29H38O2 (418.2872)


   

SCHEMBL10326064

SCHEMBL10326064

C22H42O7 (418.293)


   

1-O-Palmitoyl-D-fructopyranose|hexadecanoic 1-O-beta-D-fructoside|hexadecanoic fructoside

1-O-Palmitoyl-D-fructopyranose|hexadecanoic 1-O-beta-D-fructoside|hexadecanoic fructoside

C22H42O7 (418.293)


   

(5Z,7E)-(1R)-9,10-seco-3-thia-5,7,10(19)-cholestatriene-1,25-diol

1α,25-dihydroxy-3-deoxy-3-thiavitamin D3 / 1α,25-dihydroxy-3-deoxy-3-thiacholecalciferol

C26H42O2S (418.2905)


   

(5Z,7E)-(1S)-9,10-seco-3-thia-5,7,10(19)-cholestatriene-1,25-diol

1β,25-dihydroxy-3-deoxy-3-thiavitamin D3 / 1β,25-dihydroxy-3-deoxy-3-thiacholecalciferol

C26H42O2S (418.2905)


   

(5Z)-1,25-dihydroxy-3-thiavitamin D3 / (5Z)-1,25-dihydroxy-3-thiacholecalciferol

(5Z)-1,25-dihydroxy-3-thiavitamin D3 / (5Z)-1,25-dihydroxy-3-thiacholecalciferol

C26H42O2S (418.2905)


   

Pglcua

Hexadecylbeta-delta-glucopyranosiduronic acid

C22H42O7 (418.293)


   

bhas#28

3R-hydroxy-15R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-hexadecanoic acid

C22H42O7 (418.293)


An (omega-1)-hydroxy fatty acid ascaroside that is ascr#28 in which the pro-R hydrogen that is beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.

   

bhos#28

3R-hydroxy-16-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-hexadecanoic acid

C22H42O7 (418.293)


An omega-hydroxy fatty acid ascaroside that is (3R)-3,16-dihydroxyhexadecanoic acid (oscr#28) in which the hydroxy group at position 16 has been converted to the corresponding ascaroside. It is a metabolite of the nematode Caenorhabditis elegans.

   

1alpha,25-dihydroxy-3-deoxy-3-thiavitamin D3

(5E,7E)-(1R)-9,10-seco-3-thia-5,7,10(19)-cholestatriene-1,25-diol

C26H42O2S (418.2905)


   

1beta,25-dihydroxy-3-deoxy-3-thiavitamin D3

(5Z,7E)-(1S)-9,10-seco-3-thia-5,7,10(19)-cholestatriene-1,25-diol

C26H42O2S (418.2905)


   

(5Z)-1,25-dihydroxy-3-thiavitamin D3

(5Z,7E)-(1R)-9,10-seco-3-thia-5,7,10(19)-cholestatriene-1,25-diol

C26H42O2S (418.2905)


   

9-Hydroxy-9-apo-epsilon,psi-caroten-3-one

9-Hydroxy-9-apo-epsilon,psi-caroten-3-one

C29H38O2 (418.2872)


   

3,3-(ureylenedimethylene)bis(3,5,5-trimethylcyclohexyl) diisocyanate

3,3-(ureylenedimethylene)bis(3,5,5-trimethylcyclohexyl) diisocyanate

C23H38N4O3 (418.2944)


   

(S,S)-2,2-METHYLENEBIS(4-PHENYL-2-OXAZOLINE)

(S,S)-2,2-METHYLENEBIS(4-PHENYL-2-OXAZOLINE)

C26H44P2 (418.2918)


   

4-[(3,4-dimethylbenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid

4-[(3,4-dimethylbenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid

C24H38N2O4 (418.2831)


   

Z-N-ME-DL-ALA-OH DCHA

Z-N-ME-DL-ALA-OH DCHA

C24H38N2O4 (418.2831)


   

oxybis(ethane-2,1-diyloxyethane-2,1-diyl) bisheptanoate

oxybis(ethane-2,1-diyloxyethane-2,1-diyl) bisheptanoate

C22H42O7 (418.293)


   

1,2-DIAMINO-4-(TRIFLUOROMETHOXY)BENZENE

1,2-DIAMINO-4-(TRIFLUOROMETHOXY)BENZENE

C26H44P2 (418.2918)


   
   
   

Valbenazine

Valbenazine

C24H38N2O4 (418.2831)


C78272 - Agent Affecting Nervous System N - Nervous system

   

(3R,15R)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxyhexadecanoic acid

(3R,15R)-15-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxyhexadecanoic acid

C22H42O7 (418.293)


   

(3R)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxyhexadecanoic acid

(3R)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-hydroxyhexadecanoic acid

C22H42O7 (418.293)


   

1-{7-Cyclohexyl-6-[4-(4-Methylpiperazin-1-Yl)benzyl]-7h-Pyrrolo[2,3-D]pyrimidin-2-Yl}methanamine

1-{7-Cyclohexyl-6-[4-(4-Methylpiperazin-1-Yl)benzyl]-7h-Pyrrolo[2,3-D]pyrimidin-2-Yl}methanamine

C25H34N6 (418.2845)


   

N-Arachidonoyl Asparagine

N-Arachidonoyl Asparagine

C24H38N2O4 (418.2831)


   

[3-Carboxy-2-(13-carboxy-4-hydroxytridecanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(13-carboxy-4-hydroxytridecanoyl)oxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-Carboxy-2-(13-carboxy-6-hydroxytridecanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(13-carboxy-6-hydroxytridecanoyl)oxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-Carboxy-2-(13-carboxy-7-hydroxytridecanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(13-carboxy-7-hydroxytridecanoyl)oxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-Carboxy-2-(13-carboxy-5-hydroxytridecanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(13-carboxy-5-hydroxytridecanoyl)oxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-Carboxy-2-(13-carboxy-3-hydroxytridecanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(13-carboxy-3-hydroxytridecanoyl)oxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-carboxy-2-[(7E,9Z,11Z,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(7E,9Z,11Z,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropyl]-trimethylazanium

C25H40NO4+ (418.2957)


   

[1-Carboxy-3-(2-octanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium

[1-Carboxy-3-(2-octanoyloxy-3-propanoyloxypropoxy)propyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-(3-Butanoyloxy-2-heptanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

[3-(3-Butanoyloxy-2-heptanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[3-(3-Acetyloxy-2-nonanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

[3-(3-Acetyloxy-2-nonanoyloxypropoxy)-1-carboxypropyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

[1-Carboxy-3-(2-hexanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium

[1-Carboxy-3-(2-hexanoyloxy-3-pentanoyloxypropoxy)propyl]-trimethylazanium

C21H40NO7+ (418.2805)


   

NA-Arg 18:4(6Z,9Z,12Z,15Z)

NA-Arg 18:4(6Z,9Z,12Z,15Z)

C23H38N4O3 (418.2944)


   

NA-Asn 20:4(5Z,8Z,11Z,14Z)

NA-Asn 20:4(5Z,8Z,11Z,14Z)

C24H38N2O4 (418.2831)


   
   

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl hexadecanoate

(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl hexadecanoate

C22H42O7 (418.293)


   

n-({[(2r,4ar,7s,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

n-({[(2r,4ar,7s,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

C24H38N2O4 (418.2831)


   

1-[1-({7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl}-c-hydroxycarbonimidoyl)-1-methylethyl]-5-oxopyrrolidine-2-carboxylic acid

1-[1-({7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl}-c-hydroxycarbonimidoyl)-1-methylethyl]-5-oxopyrrolidine-2-carboxylic acid

C24H38N2O4 (418.2831)


   

(4s,5e,8r,11s,12s,13r,15s,16r)-8,11,12,13,15,16-hexahydroxy-4,8,12,16-tetramethyloctadec-5-en-7-one

(4s,5e,8r,11s,12s,13r,15s,16r)-8,11,12,13,15,16-hexahydroxy-4,8,12,16-tetramethyloctadec-5-en-7-one

C22H42O7 (418.293)


   

n-{[(7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl)oxy](hydroxy)methylidene}-2-hydroxyethanecarbamimidic acid

n-{[(7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl)oxy](hydroxy)methylidene}-2-hydroxyethanecarbamimidic acid

C24H38N2O4 (418.2831)


   

(2s)-n-[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-2-[(2r)-2-(methoxycarbonyl)-5-oxopyrrolidin-1-yl]propanimidic acid

(2s)-n-[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-2-[(2r)-2-(methoxycarbonyl)-5-oxopyrrolidin-1-yl]propanimidic acid

C24H38N2O4 (418.2831)


   

n-({[(2r,4ar,7r,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

n-({[(2r,4ar,7r,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

C24H38N2O4 (418.2831)


   

(2r)-1-(1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}-1-methylethyl)-5-oxopyrrolidine-2-carboxylic acid

(2r)-1-(1-{[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-c-hydroxycarbonimidoyl}-1-methylethyl)-5-oxopyrrolidine-2-carboxylic acid

C24H38N2O4 (418.2831)


   

(2r)-n-[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-2-[(2s)-2-(methoxycarbonyl)-5-oxopyrrolidin-1-yl]propanimidic acid

(2r)-n-[(5s,6r,7s,10r)-7-isopropyl-2,10-dimethylspiro[4.5]dec-1-en-6-yl]-2-[(2s)-2-(methoxycarbonyl)-5-oxopyrrolidin-1-yl]propanimidic acid

C24H38N2O4 (418.2831)


   

8,11,12,13,15,16-hexahydroxy-4,8,12,16-tetramethyloctadec-5-en-7-one

8,11,12,13,15,16-hexahydroxy-4,8,12,16-tetramethyloctadec-5-en-7-one

C22H42O7 (418.293)


   

n-({[(2r,4ar,7r,8as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

n-({[(2r,4ar,7r,8as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl]oxy}(hydroxy)methylidene)-2-hydroxyethanecarbamimidic acid

C24H38N2O4 (418.2831)